At $84000, New Gilead Drug Sets Off Payer Revolt

Published February 5, 2014

At 000, new Gilead drug sets off payer revolt
"I'm glad people have the new drugs, but I'm concerned about the prices," said protester Orlando Chavez, 62, a hepatitis C and HIV counselor. He worries that insurers will see Gilead's price and force patients to try a less effective, older and cheaper …
Read more on TheDay.com (blog)

Novel TEVAR System for Complicated Aortic Dissection Shows Promise
Based in part on these results, the Valiant Captivia thoracic stent graft system (Medtronic, Minneapolis, MN) received an expanded indication to treat such dissections from the US Food and Drug Administration (FDA) January 22, 2014. The stent graft …
Read more on TCTMD

Related Drug Treatment Center Orlando Information…